Previous 10 | Next 10 |
Sarissa believes Amarin leadership will continue to destroy shareholder value during this critical period; We cannot afford to maintain the status quo Sarissa has a stellar track record of success and its nominees have the experience and qualifications to help fix the problems at Amarin ...
Amarin Corp. ( NASDAQ: AMRN ) has told shareholders it should reject a slate of proposals from activist shareholder Sarissa. Amarin ( AMRN ) noted it is at "an inflection point ....Our refreshed Board are the change agents the Company needs and have actively positioned the bus...
The NEW Amarin and NEW Board is On the Right Track – Leading Independent Experts, ISS and Glass Lewis, Agree that Sarissa Representation is Not Warranted Sarissa’s Misguided Campaign to Remove Amarin’s Chairman and Gain De Facto Board Control Would be Detrimental to...
Amarin Deludes Shareholders by Presenting an Alternative Reality Where the Truth Does Not Matter Sarissa Believes that Shareholders Have Suffered Long Enough from the Nightmare under the Current Regime and Should Vote “FOR” Change at Amarin Sarissa Capital Manageme...
Sarissa is Confident that Long Suffering Amarin Shareholders Will Make Up Their Own Minds and Vote “FOR” Change at Amarin Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Saris...
Amarin Corp. ( NASDAQ: AMRN ) shareholders should vote against activist Sarissa's nominees for the board at a vote later this month, proxy advisor ISS recommended. “The board has appropriately refreshed itself and the company's positioning for commercial success appears to be i...
Independent Report Acknowledges That Sarissa’s Campaign to Remove Amarin’s Chairman and De Facto Seize Board Control Would be Detrimental to Shareholder Value Board Urges Shareholders to Follow ISS and Glass Lewis's Recommendations and Vote “AGAINST” Al...
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today corrected the record regarding the latest misinformation from Sarissa Capital Management (“Sarissa”). Contrary...
Sarissa Assumes That Amarin Knew This Conduct Was Going On and Did Nothing To Stop It Sarissa Acted to Correct the Issue, Ensuring That All Votes Submitted On The Blue Proxy Card Will Be Counted at the Amarin General Meeting Amarin Shareholders That Already Voted on the Blue Proxy...
Amarin Corporation plc (AMRN) SVB Securities Global Biopharma Conference February 14, 2023 10:40 AM ET Company Participants Karim Mikhail - President & CEO Tom Reilly - Chief Financial Officer Conference Call Participants Roanna Ruiz - SVB Securities ...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
2024-07-31 14:15:16 ET Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q2 2024 Earnings Call Jul 31, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript
Dayforce Inc. (DAY) is expected to report $0.18 for Q2 2024 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.44 for Q2 2024 Aurora Innovation Inc. (AUR) is expected to report for Q2 2024 Autohome Inc. American Depositary Shares each repr...
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...